Gapping upIn reaction to earnings/guidance:
- NK +25.5% (also announces 'promising' first in human clinical results in a novel cancer memory vaccine immunotherapy), CVNA +21.1%, ALRM +18.6%, CYBR +16.9%, PTLA +15.4%, AYX +15.3%, CARG +14.6%, HRI +13.4%, AGTC +11.8%, CROX +10.8%, ARRS +10%, SND +9.8%, TRIP +8.4%, OPRA +8.2%, MFC +7%, SNCR +6.7%, FOSL +6.5%, ZEUS +5.7%, ENDP +5.7%, LB +5.5%, GDOT +5.3%, DNR +5.3%, ORM +5.3%, NVTA +5.2%, VNDA +5.1%, TXMD +4.9%, DS +4.7%, NICE +4.7%, HOLX +4.6%, WMGI +4.2%, HIMX +4.2%, FARM +4.1%, SD +4%, ANGI +3.8%, CSOD +3.8% (also agrees to acquire Grovo Learning, Inc. for $24 mln in an all-cash deal), SRRA +3.6%, LCI +3.5%, ANSS +3.2%, PEGA +3.2%, NWSA +3.1%, AVLR +3.1%, VEON +3.1%, EDIT +2.9%, CAH +2.9%, TTWO +2.7%, SUN +2.6%, ET +2.4%, ZUMZ +2.3%, CRSP +2.1%, CVU +2.1%, LUNA +2.1%, NCLH +2.1%, XONE +1.9%, WWD +1.8%, AZUL +1.6%, WES +1.6%, PLUG +1.6%, JBGS +1.4%, TRGP +1.3%, RC +1.1%, BXC +1.1%, MRO +1%, HUBS +1%, AZN +0.9%
M&A news:
- ARRS +10% (Arris to be acquired by Commscope (COMM) for $31.75/share in cash)
- ORM +5.3% (Ready Capital (RC) and Owens Realty Mortgage (ORM) announce stock-for-stock merger)
- RC +1.1%
Other news:
- HRI +13.4% (GAMCO Investors increases active stake)
- MTZ +5.2% (to join S&P MidCap 400)
- VSTM +4.3% (continued strength following today's 15% move higher on Leukemia & Lymphoma Society collaboration news; also reported earnings)
- PAH +3.6% (after EVP Capps and 2 Directors disclosed the purchase of more than 700K shares)
- UNFI +2.1% (to join S&P SmallCap 600)
Analyst comments:
- AAXN +3.6% (upgraded to Overweight from Neutral at JP Morgan)
- SPR +1.9% (upgraded to Buy from Neutral at BofA/Merrill)
- KNX +1.5% (upgraded to Buy from Neutral at Goldman)
- AVGO +1% (resumed with a Buy at Deutsche Bank)